glp 1 drugs and levothyroxine Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels Do GLP-1 Medications Cause Thyroid
Description
Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease (NAFLD), has seen its global prevalence surge from 25% between 1990 and 2006 to 38% between 2016 and 2019
[DOI] [PubMed] [Google Scholar] 180
As many adults are on a GLP-1 today as had ever tried one a year and a half ago
Author AB has received speakers fees from AbbVie, Galapagos, Celltrion and Pfizer
In Latin America, where obesity rates have grown faster than in other parts of the world, the drug remains unaffordable for the bulk of the population
